The Launch of the Rhine-Main-Neckar Directory

Zurich 03 March 2020

Last month Biotechgate/Venture Valuation entered a partnership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region, with the goal to develop and run a publicly accessible directory of companies located in the region.

The Directory has just been launched and is accessible for free on BioRN’s website. While it features all Rhine-Main-Neckar life science companies, BioRN members have a special visibility with extended profiles. All the companies can be found both through the advanced search options and through the map search. The directory is closely integrated with the global Biotechgate Business Development Database as well as German Life Science Database, one of 30 regional directories owned by Venture Valuation. Venture Valuation believes that both, the global and the regional database, will be significantly enriched thanks to the partnership. BioRN is the fifth partner of Biotechgate/Venture Valuation in Germany.

‘We are very happy to be a partner of BioRN. The Rhine-Main-Neckar region is one of Europe’s strongest biotech hubs and we hope our directory will prove to be a great tool to give it even more visibility.’
Dr. Patrik Frei, CEO of Venture Valuation/Biotechgate

‘The Biotechgate directory is an excellent way to enhance the visibility of our cluster and – in particular – of all our members. We are very glad about this partnership because it will help us on our mission to develop the region into a world-leading life science cluster.’
Dr. Julia Schaft, Managing Director of BioRN

Address of the directory:

German Life Science Database:

BioRN –
BioRN is the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as well as promoting, representing and connecting the regional innovation stakeholders.

Venture Valuation AG –
Venture Valuation specializes in independent, third-party assessment and valuation of biotechnology, pharma and med-tech companies. Services are provided in the form of independent Valuation Reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Switzerland, Ireland, UK, Canada, USA and Asia, Venture Valuation has an experienced team of scientists and business professionals with expertise in finance, biotechnology, pharmaceutical and regulatory.

Biotechgate –
Biotechgate is a business development database that contains over 55,000 high-quality profiles of life science companies which include company descriptions, contact information, product pipeline information, financing rounds, management details, and licencing deals. In 2019 a clinical trial database containing over 500,000 records was added to Biotechgate. The new database is integrated with registries around the world.

Download the press release

Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?